FNCH

Finch Therapeutics Group, Inc. Common Stock
FNCH

Overview Fund Activity
Delisted

FNCH was delisted on the 24th of May, 2024.

Back to rankings

43 hedge funds and large institutions have $16.8M invested in Finch Therapeutics Group, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 8 closing their positions.

Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
9
Reduced
11
Closed
8
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
+$1K

Top Buyers

1
SW
1
SVB Wealth
Massachusetts
$423K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$351K
3
Millennium Management
3
Millennium Management
New York
$202K
4
VF
4
Virtu Financial
New York
$25K
5
BCM
5
Bridgeway Capital Management
Texas
$107K

Top Sellers

1
IC
1
Ikarian Capital
Texas
$397K
2
E
2
Ergoteles
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$1K
5
BFM
5
Boothbay Fund Management
New York
$40K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
51
Wells Fargo
California
$0 152 +101 +198%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$0 160 +160 New
1 2
3